KL Pharma SRL
KL Pharma reported total assets of 664,528 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of KL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
KL Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 50,690 € | ||||
| Equity | 384,626 € | ||||
| Cash | 32,062 € | ||||
| EBITDA | 88,801 € | ||||
| Total assets | 664,528 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
KL Pharma's financial analysis
- Solvency57.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KL Pharma
KL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0811.781.221
- VAT number
- BE0811781221
- Peppol
- Registered · 0208:0811781221 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 May 2009
- Registered office
- 7750 Mont-de-l'Enclus
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
KL Pharma (SRL) has been based in Mont-de-l'Enclus since 2009, active in: activities of holding companies. For 2025, it reports a net profit of 50,690 € and equity of 384,626 €; its revenue is not published. Its solvency stands at 57.9%, above the median of its sector (46.9%).
Companies similar to KL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Immobiliën Management Flamez Activities of holding companies Ninove · balance sheet 664,419 €
- Mardel Invest Activities of holding companies Oudenaarde · balance sheet 665,212 €
- Global GAS Solutions Group Removal services Kalmthout · balance sheet 663,462 €
- Svasti Activities of holding companies Raeren · balance sheet 662,685 €
- Hogwarts Activities of holding companies Mouscron · balance sheet 662,338 €
- DH Interim & Consulting Services Activities of holding companies Lede · balance sheet 661,988 €
- Gedynac Activities of holding companies Frasnes-lez-Anvaing · balance sheet 667,217 €
- Yannick Ostyn Activities of holding companies Menen · balance sheet 661,784 €
Frequently asked questions about KL Pharma
What is the revenue of KL Pharma?
KL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0811781221 for KL Pharma, if the company is VAT-registered. Its company number (CBE) is 0811.781.221.
Where is the registered office of KL Pharma?
According to the CBE register, the registered office of KL Pharma is in 7750 Mont-de-l'Enclus.
What is the equity of KL Pharma?
At the close of the 2025 financial year, the equity of KL Pharma amounts to 384,626 €, a solvency of 57.9% of total assets.
Who manages KL Pharma?
The register lists 1 active mandates at KL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →